click
Contact

Tag: IND-enabling Toxicity Studies

Contact

Search Medicilon

Preclinical CRO

Breaking New Ground in Alzheimer’s Disease! Medicilon Supports Hengrui Pharma’s SHR-3201 Injection to Secure Clinical Trial Approval

Read more
Preclinical CRO

Breaking the “King of Cancer”: First-in-Class ADC MC001. Medicilon Supports Partner Medicovestor to Secure FDA IND Clearance

Read more
Preclinical CRO

Medicilon’s Dr. Chunlin Chen Engages FDA Experts at SAPA-DC Annual Conference to Discuss Global IND Development and NAMs Technologies for Innovative Medicines

Read more

Contact Medicilon

Name(Required)
Address(Required)